127 related articles for article (PubMed ID: 9175774)
1. An alternative to phosphotyrosine-containing motifs for binding to an SH2 domain.
Rojas M; Yao S; Donahue JP; Lin YZ
Biochem Biophys Res Commun; 1997 May; 234(3):675-80. PubMed ID: 9175774
[TBL] [Abstract][Full Text] [Related]
2. Coupling of the murine protein tyrosine phosphatase PEST to the epidermal growth factor (EGF) receptor through a Src homology 3 (SH3) domain-mediated association with Grb2.
Charest A; Wagner J; Kwan M; Tremblay ML
Oncogene; 1997 Apr; 14(14):1643-51. PubMed ID: 9135065
[TBL] [Abstract][Full Text] [Related]
3. Crystal structures of the SH2 domain of Grb2: highlight on the binding of a new high-affinity inhibitor.
Nioche P; Liu WQ; Broutin I; Charbonnier F; Latreille MT; Vidal M; Roques B; Garbay C; Ducruix A
J Mol Biol; 2002 Feb; 315(5):1167-77. PubMed ID: 11827484
[TBL] [Abstract][Full Text] [Related]
4. Phosphorylation of growth factor receptor binding protein-2 by pp60c-src tyrosine kinase.
Jones DA; Benjamin CW
Arch Biochem Biophys; 1997 Jan; 337(2):143-8. PubMed ID: 9016807
[TBL] [Abstract][Full Text] [Related]
5. Formation of Shc-Grb2 complexes is necessary to induce neoplastic transformation by overexpression of Shc proteins.
Salcini AE; McGlade J; Pelicci G; Nicoletti I; Pawson T; Pelicci PG
Oncogene; 1994 Oct; 9(10):2827-36. PubMed ID: 8084588
[TBL] [Abstract][Full Text] [Related]
6. Solution structure of the SH2 domain of Grb2 complexed with the Shc-derived phosphotyrosine-containing peptide.
Ogura K; Tsuchiya S; Terasawa H; Yuzawa S; Hatanaka H; Mandiyan V; Schlessinger J; Inagaki F
J Mol Biol; 1999 Jun; 289(3):439-45. PubMed ID: 10356320
[TBL] [Abstract][Full Text] [Related]
7. The role of the Shc phosphotyrosine interaction/phosphotyrosine binding domain and tyrosine phosphorylation sites in polyoma middle T antigen-mediated cell transformation.
Blaikie PA; Fournier E; Dilworth SM; Birnbaum D; Borg JP; Margolis B
J Biol Chem; 1997 Aug; 272(33):20671-7. PubMed ID: 9252386
[TBL] [Abstract][Full Text] [Related]
8. Gi-mediated activation of the Ras/MAP kinase pathway involves a 100 kDa tyrosine-phosphorylated Grb2 SH3 binding protein, but not Src nor Shc.
Kranenburg O; Verlaan I; Hordijk PL; Moolenaar WH
EMBO J; 1997 Jun; 16(11):3097-105. PubMed ID: 9214627
[TBL] [Abstract][Full Text] [Related]
9. Structure-activity relationships of small phosphopeptides, inhibitors of Grb2 SH2 domain, and their prodrugs.
Liu WQ; Vidal M; Olszowy C; Million E; Lenoir C; Dhôtel H; Garbay C
J Med Chem; 2004 Feb; 47(5):1223-33. PubMed ID: 14971902
[TBL] [Abstract][Full Text] [Related]
10. Tyrosine phosphorylation of Shc proteins and formation of Shc/Grb2 complex correlate to the transformation of NIH3T3 cells mediated by the point-mutation activated neu.
Xie Y; Li K; Hung MC
Oncogene; 1995 Jun; 10(12):2409-13. PubMed ID: 7784091
[TBL] [Abstract][Full Text] [Related]
11. Bcr phosphorylated on tyrosine 177 binds Grb2.
Ma G; Lu D; Wu Y; Liu J; Arlinghaus RB
Oncogene; 1997 May; 14(19):2367-72. PubMed ID: 9178913
[TBL] [Abstract][Full Text] [Related]
12. Thermodynamic and structural analysis of phosphotyrosine polypeptide binding to Grb2-SH2.
McNemar C; Snow ME; Windsor WT; Prongay A; Mui P; Zhang R; Durkin J; Le HV; Weber PC
Biochemistry; 1997 Aug; 36(33):10006-14. PubMed ID: 9254595
[TBL] [Abstract][Full Text] [Related]
13. The amino-terminal Src homology 2 domain of phospholipase C gamma 1 is essential for TCR-induced tyrosine phosphorylation of phospholipase C gamma 1.
Stoica B; DeBell KE; Graham L; Rellahan BL; Alava MA; Laborda J; Bonvini E
J Immunol; 1998 Feb; 160(3):1059-66. PubMed ID: 9570517
[TBL] [Abstract][Full Text] [Related]
14. v-Src induces Shc binding to tyrosine 63 in the cytoplasmic domain of the LDL receptor-related protein 1.
Barnes H; Ackermann EJ; van der Geer P
Oncogene; 2003 Jun; 22(23):3589-97. PubMed ID: 12789267
[TBL] [Abstract][Full Text] [Related]
15. Role of tyrosine residues and protein interaction domains of SHC adaptor in VEGF receptor 3 signaling.
Fournier E; Blaikie P; Rosnet O; Margolis B; Birnbaum D; Borg JP
Oncogene; 1999 Jan; 18(2):507-14. PubMed ID: 9927207
[TBL] [Abstract][Full Text] [Related]
16. Suc1-associated neurotrophic factor target (SNT) protein is a major FGF-stimulated tyrosine phosphorylated 90-kDa protein which binds to the SH2 domain of GRB2.
Ong SH; Goh KC; Lim YP; Low BC; Klint P; Claesson-Welsh L; Cao X; Tan YH; Guy GR
Biochem Biophys Res Commun; 1996 Aug; 225(3):1021-6. PubMed ID: 8780727
[TBL] [Abstract][Full Text] [Related]
17. Potent inhibition of Grb2 SH2 domain binding by non-phosphate-containing ligands.
Yao ZJ; King CR; Cao T; Kelley J; Milne GW; Voigt JH; Burke TR
J Med Chem; 1999 Jan; 42(1):25-35. PubMed ID: 9888830
[TBL] [Abstract][Full Text] [Related]
18. Tyrosine phosphorylation of a 94-kDa protein associated with GRB2/ASH is implicated in the signal transduction of hematopoietic survival factors.
Hanazono Y; Sasaki K; Odai H; Yazaki Y; Hirai H
Biochem Biophys Res Commun; 1996 May; 222(2):330-7. PubMed ID: 8670205
[TBL] [Abstract][Full Text] [Related]
19. The SH2 domain of Shc suppresses EGF-induced mitogenesis in a dominant negative manner.
Gotoh N; Muroya K; Hattori S; Nakamura S; Chida K; Shibuya M
Oncogene; 1995 Dec; 11(12):2525-33. PubMed ID: 8545109
[TBL] [Abstract][Full Text] [Related]
20. Tyrosine phosphorylation of shc in response to B cell antigen receptor engagement depends on the SHIP inositol phosphatase.
Ingham RJ; Okada H; Dang-Lawson M; Dinglasan J; van Der Geer P; Kurosaki T; Gold MR
J Immunol; 1999 Dec; 163(11):5891-5. PubMed ID: 10570274
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
